Our treatments cater to those seeking overall health optimization
Marsicano and Lutz, 1999)
What cardiovascular benefits does SLU-PP-332 demonstrate in research
Pros: Cons: Best for: Most patients, especially those new to self-injection
an alternative funded GLP-1 receptor agonist) Vildagliptin (oral, funded), taken either as separate metformin and vildagliptin tablets, or a combination vildagliptin + metformin formulation A sulfonylurea (oral, funded), such as gliclazide or glipizide Pioglitazone (oral, funded) The decision about which medicine to use should take into account any contraindications, cardiovascular co-morbidities, risk of hypoglycaemia, effects on weight, medicines interactions, adverse effects and eligibility for funding (Table 2 and Initiating funded treatment)
Evaluating leading suppliers involves comparing key metrics relevant to B2B procurement decisions